Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment-Reference-Cited by-同舟云学术

Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment

Published:2018-10 Issue: Volume:156 Page:22-31
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Novotná Eva,Büküm Neslihan,Hofman Jakub,Flaxová Michaela,Kouklíková Etela,Louvarová Dagmar,Wsól Vladimír

Funder

Czech Science Foundation

EFSA-CDN

Charles University

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference65 articles.

1. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs;Roskoski;Pharmacol. Res.,2016

2. Cyclin dependent kinases in cancer: potential for therapeutic intervention;Canavese;Cancer Biol. Ther.,2012

3. Inhibitors of cyclin-dependent kinases as cancer therapeutics;Whittaker;Pharmacol. Ther.,2017

4. In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202;Raynaud;Clin. Cancer Res.,2005

5. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine);McClue;Int. J. Cancer,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08

2. Bioinformatics Analysis, ceRNA Network Construction and Prediction of Potential Therapeutic Drug Effects Based on TCGA and CMap Datasets in Endometrial Cancer;J BIOL REG HOMEOS AG;2023

3. Comprehensive analysis of the function of helicobacter-associated ferroptosis gene YWHAE in gastric cancer through multi-omics integration, molecular docking, and machine learning;Apoptosis;2023-11-24

4. Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment;Journal of Medicinal Chemistry;2023-07-06

5. In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics;Molecules;2023-04-27